vaccine development

See the following -

Approval Of A Coronavirus Vaccine Would Be Just The Beginning - Huge Production Challenges Could Cause Long Delays

The race for a SARS-CoV-2 vaccine is well underway. It's tempting to assume that once the first vaccine is approved for human use, all the problems of this pandemic will be immediately solved. Unfortunately, that is not exactly the case. Developing a new vaccine is only the first part of the complex journey that's supposed to end with a return to some sort of normal life. Producing hundreds of millions of vaccines for the U.S. - and billions for the world as a whole - will be no small feat. There are many technical and economic challenges that will need to be overcome somehow to produce millions of vaccines as fast as possible.

Read More »

RSNA Launches International COVID-19 Open Radiology Database

Press Release | Radiological Society of North America (RSNA), RSNA COVID-19 AI Task Force | June 25, 2020

The Radiological Society of North America (RSNA) and the RSNA COVID-19 AI Task Force today announced the launch of the RSNA International COVID-19 Open Radiology Database (RICORD). RICORD is envisioned as the largest open database of anonymized COVID-19 medical images in the world. More than 200 institutions around the world have expressed their interest in participating. The database will include supporting clinical information and expert annotations. It will be freely available to the global research and education communities.

Read More »